ImmunoCellular Therapeutics Ltd (NYSE American:IMUC)

0.2433
Delayed Data
As of Feb 16
 +0.0033 / +1.37%
Today’s Change
0.17
Today|||52-Week Range
3.60
-23.01%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.24
Today’s open0.25
Day’s range0.24 - 0.25
Volume280,282
Average volume (3 months)2,740,097
Market cap$5.8M
Data as of 3:58pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-31.50%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.14

Competitors

 Today’s
change
Today’s
% change
SGLBSigma Labs Inc+0.01+0.57%
YTENYield10 Bioscience I...+0.10+6.54%
BASIBioanalytical System...+0.15+10.49%
OPGNOpGen Inc+0.17+9.14%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$0.00
Annual profit (last year)-$22.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Calabasas, California

Forecasts